Improving Access to Care for Veterans With Memory Loss
Purpose
This study evaluates a care delivery protocol to improve access to care for Veterans with Alzheimer's Disease and Related Disorders (ADRD). A randomized controlled trial will enroll Veterans with mild cognitive impairment or early dementia at VA Pittsburgh. The ADRD care delivery protocol integrates telehealth, advanced diagnostics, and streamlined workflows to expedite screening for eligibility for amyloid targeting therapies.
Condition
- Alzheimer Disease
Eligibility
- Eligible Ages
- Over 18 Years
- Eligible Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- Diagnosis of mild cognitive impairment or mild dementia due to suspected or confirmed AD with a 5 minute telephone MoCA score >7 - Meets VA MUE inclusion/
Exclusion Criteria
for mAb therapy for AD - Enrolled in VA care - Lives in a home setting (i.e., not in an institutional setting such as a nursing home, Community Living Center, or hospital) - Has a working telephone - 18 years and older - Able to communicate in English - Willing to give informed consent. Exclusion Criteria: - None
Study Design
- Phase
- N/A
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Single Group Assignment
- Primary Purpose
- Health Services Research
- Masking
- None (Open Label)
Arm Groups
| Arm | Description | Assigned Intervention |
|---|---|---|
|
Experimental ADRD Care Delivery Protocol |
Patients will undergo telehealth preparedness assessment, cognitive screening, and blood biomarker testing prior to the initial consultation with the specialist. |
|
|
No Intervention Usual Care |
Patients will undergo usual care with all evaluation and testing at the discretion of the specialist. |
|
Recruiting Locations
Pittsburgh, Pennsylvania 15240
More Details
- Status
- Recruiting
- Sponsor
- VA Pittsburgh Healthcare System